Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: PRO Onc Assay and Treatment|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: SCRI Development Innovations, LLC
Collaborators: Prometheus Laboratories|Genentech, Inc.